Arginine Vasopressin Disorder (Diabetes Insipidus)

Overview

4.5 out of 5 (45 Reviews)

Credits

1.50

Post Assessment Questions

8

Start Date

1 Sep 2023

Last Review Date

11 Jan 2024

Expiration Date

31 Aug 2026

Estimated Time To Finish

90 Minutes


Unlimited Physician CME

Stay up to date on the latest medical knowledge with 6669 CME activities. In these online self-assessment activities, read our reference articles and test your knowledge with more than 7919 hours of CME.

Learn About Lifetime CME

6 Month Unlimited Physician CME

Access to all the Unlimited Physician CME activities in all specialties.

$199 per half year per user

1 Year Unlimited Physician CME

Access to all the Unlimited Physician CME activities in all specialties.

$299 per 1 year per user
 
Need Help?  If you have a system or content concerns, please contact support@statpearls.com

Activity Description

Arginine vasopressin disorder, formerly known as diabetes insipidus (DI), is a disease process that results in either decreased release of antidiuretic hormone (ADH, also known as vasopressin or AVP) or reduced response to ADH, causing electrolyte imbalances. There are two types of arginine vasopressin disorder, namely arginine vasopressin deficiency, AVP-D, (formerly known as central DI) and arginine vasopressin resistance, AVP-R (formerly known as nephrogenic DI), and each has congenital and acquired causes. Arginine vasopressin disorder is caused by a problem with vasopressin production in the pituitary gland (deficiency) or the action of vasopressin in the kidneys (resistance). Based on the site of its pathology, it can be divided into Arginine vasopressin deficiency (AVP-D)  and Arginine vasopressin resistance (AVP-R). This activity reviews the etiology, presentation, evaluation, and management of diabetes insipidus and the role of the interprofessional team in evaluating, diagnosing, and managing this condition.


Target Audience

This activity has been designed to meet the educational needs of physicians, physician associates, nurses, pharmacists, and nurse practitioners.

Learning Objectives

At the conclusion of this activity, the learner will be better able to:

  • Differentiate between the two primary categories of arginine vasopressin disorder and understand their respective pathophysiology.

  • Interpret the factors in evaluating a patient with suspected arginine vasopressin disorder, including laboratory analysis.

  • Differentiate the treatment options for arginine vasopressin disorder, depending on the specific etiology.

  • Communicate the importance of improving coordination among the interprofessional team to enhance care for patients affected by arginine vasopressin disorder.

Disclosures

StatPearls, LLC requires everyone who influences the content of an educational activity to disclose relevant financial relationships with ineligible companies that have occurred within the past 24 months. Ineligible companies are organizations whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients. All relevant conflict(s) of interest have been mitigated. Hover over contributor names for financial disclosures. Others involved in planning this educational activity have no relevant financial relationships to disclose.

Commercial Support: This activity has received NO commercial support.

Continuing Education Accreditation Information

In support of improving patient care, StatPearls, LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.

 

Physicians and Physician Associates: StatPearls, LLC designates this enduring material for a maximum of 1.50 AMA PRA Category 1 Credit(s)TM. Physicians and PAs should only claim credit commensurate with the extent of their participation in the activity.

American Board of Anesthesiology: This activity contributes to the CME component of the American Board of Anesthesiology’s redesigned Maintenance of Certification in AnesthesiologyTM (MOCA®) program, known as MOCA 2.0®. Please consult the ABA website, www.theABA.org, for a list of all MOCA 2.0 requirements.

American Board of Internal Medicine: Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 1.50 MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.

American Board of Pathology: Successful completion of this Continuing Certification activity, which includes participation in the evaluation component, enables the participant to earn up to 1.50 Lifelong Learning (CME) credits in the American Board of Pathology’s Continuing Certification Program.

American Board of Pediatrics: Successful completion of this CME activity, which includes participation in the evaluation component, enables the learner to earn up to 1.50 MOC points in the American Board of Pediatrics’ (ABP) Maintenance of Certification (MOC) program. It is the CME activity provider’s responsibility to submit learner completion information to ACCME for the purpose of granting ABP MOC credit.

American Board of Surgery: Successful completion of this CME activity, which includes participation in the evaluation component, enables the learner to earn credit toward the CME and Self-Assessment requirement(s) of the American Board of Surgery’s Continuous Certification program. It is the CME activity provider's responsibility to submit learner completion information to ACCME for the purpose of granting ABS credit.

Royal College of Physicians and Surgeons of Canada: Through an agreement between the Accreditation Council for Continuing Medical Education and the Royal College of Physicians and Surgeons of Canada, medical practitioners participating in the Royal College MOC Program may record completion of accredited activities registered under the ACCME’s “CME in Support of MOC” program in Section 3 of the Royal College’s MOC Program.

Please consult your professional licensing board for information on the applicability and acceptance of continuing education credit for this activity.

Method of Participation and Credit

  1. Register for the activity.    
  2. Review the target audience, learning objectives, and disclosure information.
  3. Study the educational content of the enduring material.
  4. Choose the best answer to each activity test question. To receive credit and a certificate, you must pass the test questions with a minimum score of 100%.
  5. Complete the post-activity assessment survey.

If you have concerns regarding the CE/CME system, please contact support@statpearls.com.

Disclaimer

This educational activity was planned and produced in accordance with the ACCME Standards for Integrity and Independence in Accredited Continuing Education. Faculty may discuss investigational products or off-label uses of products regulated by the FDA. Readers should verify all information before employing any therapies described in this educational activity.

The information provided for this activity is for continuing education purposes only and is not meant to substitute for the independent medical/clinical judgment of a healthcare provider relative to diagnostic and treatment options of a specific patient’s medical condition. The information presented does not necessarily reflect the views of StatPearls or any commercial supporters of educational activities on statpearls.com. StatPearls expressly disclaims responsibility for any adverse consequences resulting directly or indirectly from information in the course, for undetected error, or through a participant's misunderstanding of the content.

Unapproved Uses of Drugs/Devices: In accordance with FDA requirements, the audience is advised that information presented in this continuing education activity may contain references to unlabeled or unapproved uses of drugs or devices. Please refer to the FDA-approved package insert for each drug/device for full prescribing/utilization information.

Cancellation Policy: Please see the cancellation policy. StatPearls, LLC reserves the right to cancel any course due to unforeseen circumstances.

 

 
 

Reviews

Stephanie C. on 6/11/2021

Sami A. on 7/26/2021

John L. on 9/29/2021

Hurline S. on 10/19/2021

Gibi G. on 11/10/2021

Ebony C. on 12/27/2021

Aroona S. on 1/11/2022

cyvada s. on 5/12/2022

Alessandra T. on 5/15/2022

Manish Kumar S. on 6/1/2022

Louie L. on 6/6/2022

K.Navanitha R. on 7/15/2022

Aileen H. on 7/17/2022

Denise H. on 7/20/2022

Toni-Marie P. on 10/12/2022

Raymond A. on 10/25/2022

Sweta S. on 2/18/2023

James A. on 3/15/2023

Przemyslaw L. on 3/15/2023

Alice H. on 5/10/2023

Nicole F. on 9/25/2023

Chastity H. on 9/24/2023

Lewis B. on 10/4/2023

kristi f. on 10/5/2023

A M. on 11/8/2023

nduka-obi o. on 12/27/2023

Anne S. on 12/29/2023

Michael W. on 1/5/2024

Thomas M. on 1/19/2024

Michael F. on 1/22/2024

Anuradha S. on 2/5/2024

Mark H. on 2/17/2024

Puneet T. on 2/22/2024

Said a. on 2/24/2024

Derrick R. on 3/7/2024

bogdana t. on 3/8/2024

michael a. on 4/8/2024

Evelyn C. on 4/14/2024

Kathryn H. on 4/16/2024

Adam B. on 5/11/2024

Mamta B. on 5/17/2024

Alpana S. on 5/18/2024

NISHA N. on 6/11/2024

ishvar p. on 6/11/2024

Jack K. on 7/22/2024

Unlimited Physician CME

Stay up to date on the latest medical knowledge with 6669 CME activities. In these online self-assessment activities, read our reference articles and test your knowledge with more than 7919 hours of CME.

Learn About Lifetime CME

6 Month Unlimited Physician CME

Access to all the Unlimited Physician CME activities in all specialties.

$199 per half year per user

1 Year Unlimited Physician CME

Access to all the Unlimited Physician CME activities in all specialties.

$299 per 1 year per user